Reducing peritoneal recurrence in colorectal cancer is critically important because peritoneal metastases are associated with a particularly poor prognosis and significantly lower ...

Data demonstrate sustained peritoneal disease control and reinforce the potential of Oncoinvent's novel radiopharmaceutical therapy to target peritoneal disease in colorectal cancer OSLO ...

The Dutch Healthcare Institute (NZa) has scrapped certain expensive cancer inhibitors from the basic health insurance package ...

Sally Maidment, a cancer survivor from Grayshott, encourages others to join the UK-wide research registry, highlighting the ...

A diagnosis of 4 stage ovarian cancer can be devastating. However, advances in medical science are helping patients and ...

During a live event, Hari Deshpande, MD, and participants discussed the DeFi trial and the management of nirogacestat in ...

To prevent ovarian cancers, fallopian tube removal is on an upsurge — and diagnostic manuals are finally catching up.

It comes amid a rise in bowel cancer striking people in their 20s, 30s and 40s -a phenomenon that has baffled doctors around ...

Amplia Therapeutics Limited (ASX: ATX), ("Amplia" or the "Company"), is pleased to announce important new data from our ongoing ACCENT clinical trial in pancreatic cancer. The trial is investigating ...

Actress Kara Tointon shared her "overwhelming sense of relief" over having a double mastectomy following a cancer gene test.

New blood tests promise to detect malignancies before they’ve spread. But proving that these tests actually improve outcomes ...

Cancer cases are on the rise in young people but misdiagnosis remains an issue, with everything from anxiety to menopause ...